| 36.76 Data as of Mar 10 |  -0.93 / -2.47%Today’s Change | 19.10 Today|||52-Week Range 38.60 | +27.42% Year-to-Date |
| Previous close | 37.69 |
| Today’s open | 37.45 |
| Day’s range | -- - -- |
| Volume | 16,757 |
| Average volume (3 months) | 23,442 |
| Market cap | $869.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +136.99% |
| Earnings growth (this year) | +13.41% |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | +20.72% |
| P/E ratio | 13.6 |
| Price/Sales | 2.31 |
| Price/Book | 5.13 |
| Today’s change | Today’s % change | |
|---|---|---|
| HZNPHorizon Pharma Inc | +0.40 | +3.03% |
| ANACAnacor Pharmaceutica... | -0.88 | -4.16% |
| EPZMEpizyme Inc | +0.54 | +2.00% |
| PRTAProthena Corporation... | +0.05 | +0.13% |
| Next reporting date | March 13, 2014 |
| EPS forecast (this quarter) | $0.38 |
| Annual revenue (last year) | $184.8M |
| Annual profit (last year) | $45.2M |
| Net profit margin | 24.47% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO David Xiaoying Gao |
CFO, Treasurer & Vice President-Compliance Ming Yang |
Corporate headquarters Beijing, Beijing |
.
